University of Utah, Salt Lake City, UT.
Benioff Children's Hospital, University of California-San Francisco, San Francisco, CA.
Pediatr Crit Care Med. 2022 Jul 1;23(7):e319-e328. doi: 10.1097/PCC.0000000000002959. Epub 2022 Apr 22.
To describe health-related quality of life (HRQL) and functional outcomes in pediatric acute respiratory distress syndrome (ARDS) and to determine risk factors associated with poor outcome defined as death or severe reduction in HRQL at 28 days or ICU discharge.
Prospective multisite cohort-outcome study conducted between 2019 and 2020.
Eight academic PICUs in the United States.
Children with ARDS based on standard criteria.
Patient characteristics and illness severity were collected during PICU admission. Parent proxy-report measurements were obtained at baseline, day 28/ICU discharge, month 3, and month 9, utilizing Pediatric Quality of Life Inventory and Functional Status Scale (FSS). A composite outcome evaluated using univariate and multivariate analysis was death or severe reduction in HRQL (>25% reduction in the Pediatric Quality of Life Inventory at day 28/ICU discharge.
This study enrolled 122 patients with a median age of 3 years (interquartile range, 1-12 yr). Common etiologies of ARDS included pneumonia ( n = 63; 52%) and sepsis ( n = 27; 22%). At day 28/ICU discharge, half (50/95; 53%) of surviving patients with follow-up data reported a greater than 10% decrease in HRQL from baseline, and approximately one-third of participants ( n = 19/61; 31%) reported a greater than 10% decrease in HRQL at 9 months. Trends in FSS were similar. Of 104 patients with data, 47 patients (45%) died or reported a severe decrease of greater than 25% in HRQL at day 28/ICU discharge. Older age was associated with an increased risk of death or severe reduction in HRQL (odds ratio, 1.08; CI, 1.01-1.16).
Children with ARDS are at risk for deterioration in HRQL and FSS that persists up to 9 months after ARDS. Almost half of children with ARDS experience a poor outcome including death or severe reduction in HRQL at day 28/ICU discharge.
描述儿科急性呼吸窘迫综合征(ARDS)患儿的健康相关生活质量(HRQL)和功能结局,并确定与 28 天或 ICU 出院时死亡或 HRQL 严重下降定义的不良结局相关的危险因素。
2019 年至 2020 年进行的前瞻性多中心队列-结局研究。
美国 8 家学术 PICUs。
符合标准的 ARDS 患儿。
在 PICU 住院期间收集患者特征和疾病严重程度。利用儿童生活质量量表和功能状态量表(FSS),在基线、28 天/ICU 出院、3 个月和 9 个月时,由患儿父母进行代理报告测量。使用单变量和多变量分析评估复合结局为死亡或 HRQL 严重下降(28 天/ICU 出院时儿童生活质量量表降低>25%)。
本研究纳入了 122 例中位年龄为 3 岁(四分位距,1-12 岁)的患儿。ARDS 的常见病因包括肺炎(n=63;52%)和脓毒症(n=27;22%)。在 28 天/ICU 出院时,50/95(53%)例有随访数据的存活患儿报告 HRQL 基线比基线下降>10%,约三分之一的参与者(n=19/61;31%)报告 HRQL 在 9 个月时下降>10%。FSS 的趋势相似。在 104 例有数据的患儿中,47 例(45%)患儿在 28 天/ICU 出院时死亡或报告 HRQL 严重下降>25%。年龄较大与死亡或 28 天/ICU 出院时 HRQL 严重下降(比值比,1.08;95%CI,1.01-1.16)的风险增加相关。
ARDS 患儿存在 HRQL 和 FSS 恶化的风险,这种恶化可持续至 ARDS 后 9 个月。近一半的 ARDS 患儿在 28 天/ICU 出院时出现不良结局,包括死亡或 HRQL 严重下降。